FDA authorizes pre-exposure prophylaxis for COVID-19
- Invivyd was granted an Emergency Use Authorization by the United States FDA for PEMGARDA, a pre-exposure prophylaxis (PrEP) treatment for COVID-19. The administration is authorizing the therapy for moderately to severely immunocompromised patients. PEMGARDA, known as pemivibart and previously called VYD222, is a half-life extended monoclonal...
